Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results

Go back to Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results

Medpace Holdings (MEDP) Tops Q4 EPS by 10c, Revenues Beat; Offers FY20 EPS/Revenue Mid-Point Guidance Above Consensus

February 24, 2020 4:30 PM EST

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $0.85, $0.10 better than the analyst estimate of $0.75. Revenue for the quarter came in at $229.9 million versus the consensus estimate of $221.73 million.

Revenue of $229.9 million in the fourth quarter of 2019 increased 19.7% from revenue of $192.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%; Full year 2019 revenue of $861.0 million increased 22.2% from full year 2018.Net new business awards were $281.1 million in the fourth quarter of 2019, representing an increase of 21.6% from net new business awards of $231.2 million for the comparable prior-year period, which... More